Anatara Lifesciences Ltd

ASX:ANR ISIN:AU000000ANR0

Anatara Lifesciences ASX ANRAnatara Lifesciences (ASX:ANR) is developing and commercialising innovative, evidence-based products for gastrointestinal health where there is significant unmet need. Anatara is a life sciences company with expertise in developing products for animal and human health. Anatara is focused on building a pipeline of human gastrointestinal health products. Underlying this product development program is our commitment to delivering real outcomes for patients and strong value for our shareholders. For more information, please visit www.anataralifesciences.com.

     

News

Anatara Lifesciences Ltd (ASX:ANR) Quarterly Report

🕔7/29/2020 10:29:44 AM 258

While focussing financial resources on development of GaRP, Anatara has been evaluating development, in collaboration with third parties, additional dosage forms for piglets and to utilise Anatara's intellectual property in other species including in-feed formulations for piglets, formulations for aquaculture and formulations for poultry.

Read Full Article

Anatara Lifesciences Ltd (ASX:ANR) Partnering Update

🕔6/23/2020 1:04:50 PM 1352

Anatara is nearing conclusion of a process of due diligence and negotiation with many of the world's leading animal health companies. Anatara's objective being to partner with a company or companies to register Detach(R) in key overseas markets.

Read Full Article

Anatara Lifesciences Ltd (ASX:ANR) Appendix 4C - Quarterly

🕔4/27/2020 10:02:06 AM 1311

Anatara Lifesciences Ltd (ASX:ANR) is pleased to release its Appendix 4C for the quarter ending 31st March 2020. The Company's cash plus term deposits at the end of the quarter stood at $3.3m.

Read Full Article

Anatara Lifesciences Ltd (ASX:ANR) Market Update COVID-19

🕔4/7/2020 10:06:03 AM 1692

Anatara Lifesciences Ltd (ASX:ANR) provides an update on the impact to the Company of the COVID-19 pandemic.

Read Full Article

Anatara Lifesciences Ltd (ASX:ANR) Half Yearly Report and Accounts

🕔2/25/2020 12:19:48 PM 1608

Anatara Lifesciences Ltd (ASX:ANR) present their report on the consolidated entity consisting of Anatara Lifesciences Ltd and the entities it controlled at the end of, or during, the half-year ended 31 December 2019.

Read Full Article

Anatara Lifesciences Ltd (ASX:ANR) CEO Steven Lydeamore Interview

🕔2/21/2020 8:39:05 PM 1637

Anatara Lifesciences Ltd (ASX:ANR) CEO Steven Lydeamore was recently interviewed by Stockhead, for its "90 Seconds With" interview series. Steve provided an overview of the Company's key milestones for the next 12 months.

Read Full Article

Anatara Lifesciences Ltd (ASX:ANR) Preclinical Program Summary

🕔1/22/2020 11:23:32 AM 4412

Anatara Lifesciences Ltd (ASX:ANR) is pleased to provide a summary of the preclinical studies conducted to date for its Gastrointestinal ReProgramming (GaRP) dietary supplement as it targets commencement of a human clinical trial in 2Q 2020.

Read Full Article

Anatara Lifesciences Ltd (ASX:ANR) Quarterly Cashflow

🕔1/15/2020 8:40:10 AM 4399

Anatara Lifesciences Ltd (ASX:ANR) is pleased to release its Appendix 4C for the quarter ending 31st December 2019. The Company's cash plus term deposits at the end of the quarter stood at $4.30m

Read Full Article

Anatara Lifesciences Ltd (ASX:ANR) Finalises Draft Protocol for IBS Clinical Trial

🕔12/20/2019 8:21:26 AM 4269

Anatara Lifesciences (ASX:ANR) is pleased to provide an update on the protocol for its clinical trial in irritable bowel syndrome (IBS) for its GaRP dietary supplement.

Read Full Article

Anatara Lifesciences Ltd (ASX:ANR) Achieves Preclinical Milestone

🕔12/19/2019 1:06:55 PM 4030

Anatara Lifesciences (ASX:ANR) is pleased to provide an update on its GaRP dietary supplement preclinical milestones, which is being developed to specifically target two human gastrointestinal disorders, inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS).

Read Full Article
###

56,083 COMPANY PROFILE VIEWS

  • This Page Viewed: (Last 7 Days: 136) (Last 30 Days: 553) (Since Published: 56083) 

Company Data

    Headquarters
  • Level 3, 62 Lygon Street
    Carlton South, VIC, 3053
    Australia
  • Principal Sector
  • Biotech 
  • Principal Industry
  • Biotechnology 
  • Homepage
  • www.anataralifesciences.com
  • E:
  • info@anataralifesciences.com

Company Reports